Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The need to develop more sensitive tools to accurately detect clinical response to treatment in ADHD.

× No keyword cloud information.

7 in total

Review 1. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression.

Authors: A A Nierenberg; L M DeCecco
Journal: J Clin Psychiatry Date: 2001 Impact factor: 4.384

2. Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes?

Authors: Amy R Perwien; Christopher J Kratochvil; Douglas E Faries; Brigette S Vaughan; Thomas Spencer; Ronald T Brown
Journal: J Child Adolesc Psychopharmacol Date: 2006-12 Impact factor: 2.576

3. Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.

Authors: Luigi Mazzone; Laura Reale; Valeria Mannino; Mariadonatella Cocuzza; Benedetto Vitiello
Journal: CNS Drugs Date: 2011-06-01 Impact factor: 5.749

4. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.

Authors: Thomas J Spencer; Timothy E Wilens; Joseph Biederman; Richard H Weisler; Stephanie C Read; Raymond Pratt
Journal: Clin Ther Date: 2006-02 Impact factor: 3.393

The need to develop more sensitive tools to accurately detect clinical response to treatment in ADHD.

Review 1. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression.

2. Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes?

3. Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.

4. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.

Review 5. Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder.

6. The Clinical Global Impressions scale: errors in understanding and use.

7. The improved Clinical Global Impression Scale (iCGI): development and validation in depression.